Insmed Inc Asset Turnover Ratio (INSM), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Insmed Inc  (NASDAQ: INSM)
 

Insmed Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Insmed Inc asset turnover ratio, the ability of Insmed Inc's assets to generate revenue in the first quarter 2026, increased sequentially to 0.32 in the first quarter (Mar 31 2026), a new company high.

Within sector 104 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 726 to 2121.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INSM Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 15.74 % 12.69 % 15.41 % 37.63 % 56.79 %
Y / Y Revenue Change 301.22 % 287.83 % 77.99 % 24.06 % -8.49 %
Asset Turnover Ratio (TTM) 0.32 0.24 0.16 0.14 0.14
INSM's Total Ranking # 2121 # 726 # 2597 # 1935 # 2215
Seq. Asset Change -8.33 % -3.72 % -4.8 % 37.76 % -10.75 %
Seq. Revenue Change 17.53 % 99.45 % 41.53 % 20.93 % 13.61 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 105
Healthcare Sector # 350
Overall Market # 2121

Asset Turnover Ratio Statistics
High Average Low
0.32 0.2 0.14
(Mar 31 2026)   (Jun 30 2025)




INSM Company Profile • Back to INSM Efficiency Comparisons • Compare INSM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Pacs Group Inc   0.97 $ 5,432.276  Millions$ 5,594.153  Millions
Caredx Inc   0.97 $ 412.820  Millions$ 425.214  Millions
Orthofix Medical Inc   0.97 $ 824.944  Millions$ 851.754  Millions
Neuroone Medical Technologies Corp  0.97 $ 9.721  Millions$ 10.064  Millions
Trisalus Life Sciences Inc   0.96 $ 44.183  Millions$ 46.023  Millions
Nexgel Inc   0.96 $ 10.382  Millions$ 10.848  Millions
Embecta Corp   0.96 $ 1,043.100  Millions$ 1,092.100  Millions
Travere Therapeutics Inc   0.95 $ 536.195  Millions$ 563.567  Millions
Neuropace Inc   0.95 $ 98.926  Millions$ 104.458  Millions
Select Medical Holdings Corp  0.95 $ 5,521.134  Millions$ 5,830.411  Millions
Omada Health Inc   0.94 $ 281.916  Millions$ 299.661  Millions
Regen Biopharma Inc   0.94 $ 0.237  Millions$ 0.252  Millions
Corcept Therapeutics Inc  0.94 $ 769.096  Millions$ 819.215  Millions
Madrigal Pharmaceuticals Inc   0.93 $ 1,132.490  Millions$ 1,216.189  Millions
Ufp Technologies Inc   0.93 $ 608.621  Millions$ 654.310  Millions
Accuray Incorporated  0.93 $ 427.893  Millions$ 461.224  Millions
Community Health Systems Inc   0.92 $ 12,291.000  Millions$ 13,316.000  Millions
Ironwood Pharmaceuticals inc   0.92 $ 361.514  Millions$ 392.619  Millions
Insulet Corporation  0.92 $ 2,900.800  Millions$ 3,169.025  Millions
Liquidia Corporation  0.91 $ 288.065  Millions$ 315.715  Millions
Apyx Medical Corp  0.90 $ 55.304  Millions$ 61.355  Millions
Cue Biopharma Inc   0.90 $ 32.731  Millions$ 36.360  Millions
Pediatrix Medical Group Inc   0.90 $ 1,931.686  Millions$ 2,154.624  Millions
Verrica Pharmaceuticals Inc   0.90 $ 37.161  Millions$ 41.480  Millions
Genedx Holdings Corp   0.89 $ 442.908  Millions$ 496.944  Millions
Lakeland Industries Inc   0.89 $ 193.318  Millions$ 217.323  Millions
Enhabit Inc   0.89 $ 1,064.900  Millions$ 1,199.925  Millions
Protalix Biotherapeutics inc   0.88 $ 76.381  Millions$ 86.358  Millions
Teladoc Health Inc   0.88 $ 2,514.453  Millions$ 2,859.528  Millions
Alnylam Pharmaceuticals Inc   0.88 $ 4,286.923  Millions$ 4,878.390  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.